Camptosar irinotecan package insert
Web1 Camptosar® 2 irinotecan hydrochloride injection 3 4 For Intravenous Use Only 5 WARNINGS 6 CAMPTOSAR Injection should be administered only under the supervision of a 7 physician who is experienced in the use of cancer chemotherapeutic agents. Appropriate 8 management of complications is possible only when adequate diagnostic and treatment WebView Fresenius Kabi's Oncology Product Portfolio including Irinotecan Hydrochloride Injection – cross references to branded drug Camptosar®. ... Cross references to branded drug Camptosar ® 100 mg per 5 mL Order. Package Insert Download NDC No. 63323-193-55 Product No 109355 Description SD Amber Vial ...
Camptosar irinotecan package insert
Did you know?
WebIrinotecan (Camptosar) patient drug information (UpToDate) [4] History of changes in FDA indication 6/14/1996: Initial accelerated approval for the treatment of patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following 5 … WebIRINOTECAN Hydrochloride Injection, USP* Brand Name Equivalent: CAMPTOSAR®(CAMPTOSAR is a registered trademark of Yakult Honsha Company, Ltd.) Therapeutic Category: Antineoplastic Agent PreventIV Measures®Features: Easy-to-read drug name and dosage strength to aid in identifying the right product
WebCamptosar (irinotecan) dosing, indications, interactions, adverse effects, and more Drugs & Diseases irinotecan (Rx) Brand and Other Names: Camptosar Classes: Antineoplastics, Topoisomerase... WebThe CAMPTOSAR (irinotecan) package insert recommends a reduced initial dose be considered for patients homozygous for the UGT1A1*28 allele and are at an increased risk for neutropenia following initiation of CAMPTOSAR treatment. AutoGenomics Doc EM-34028E (English) Rev. G Page (CO 2307) October 2012
http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Irinotecan_monograph.pdf WebSep 26, 2024 · Camptosar Dosage Generic name: IRINOTECAN HYDROCHLORIDE 20mg in 1mL Dosage form: injection, solution Drug class: Miscellaneous antineoplastics Medically reviewed by Drugs.com. Last updated on Sep 26, 2024. Colorectal Cancer Combination Regimens 1 and 2 Administer CAMPTOSAR as a 90-minute intravenous …
WebTrade Name: CAMPTOSAR; CAMPTO Chemical Family: Mixture Intended Use: Pharmaceutical product used as Antineoplastic 2. HAZARDS IDENTIFICATION ... Irinotecan Hydrochloride 100286-90-6 Not Listed Mut. Cat.3;R68 Repr. Cat.3;R61 Xn;R22 2% Sodium hydroxide 1310-73-2 215-185-5 C;R35 **
WebApr 1, 2024 · US Brand Name Camptosar Novaplus Irinotecan Hydrochloride Descriptions Irinotecan injection is given together with other medicines (eg, 5-fluorouracil, leucovorin) to treat patients with metastatic cancer (a cancer that … in an industry with low marginsWebCAMPTOSAR Injection (irinotecan hydrochloride injection) is an antineoplastic agent of the topoisomerase I inhibitor class. CAMPTOSAR is supplied as a sterile, pale yellow, clear, aqueous solution. Each... Read more Did you find an answer to your question? Yes No 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action inaz communication system intercosWebMar 21, 2024 · Irinotecan (Camptosar ©, CPT-11), a topoisomerase I inhibitor, is a commonly used cytotoxic chemotherapeutic in the treatment of multiple malignancies, particularly of gastrointestinal origin. Dysarthria secondary to irinotecan has been described as a rare side effect in a few case reports with limited data to recommend appropriate … in an inebriated way crossword clue 7 lettersWebThe CAMPTOSAR (irinotecan) package insert recommends a reduced initial dose be considered for patients homozygous for the UGT1A1*28 allele and are at an increased risk for neutropenia following initiation of CAMPTOSAR treatment. AutoGenomics Doc EM-34028E (English) Rev. K (CO 4180A) Feb. 2024 in an infant fluid retention is monitored byWebIrinotecan liposome injection (also known MM-398 and PEP02) is a liposomal formulation of the topoisomerase I inhibitor irinotecan. It is a nanotherapeutic agent that consists of 80,000 molecules of the chemotherapeutic irinotecan encapsulated in … in an inequality which circle is openWebIn addition, homozygosity for *28 is specified as the primary risk factor in the Camptosar (irinotecan) package insert. 29 Consequently, we chose to limit the review of clinical validity to these ... inaz cosmetics websiteWebCAMPTOSAR Injection (irinotecan hydrochloride injection) is an antineoplastic agent of the topoisomerase I inhibitor class. CAMPTOSAR is supplied as a sterile, pale yellow, clear, aqueous solution. Each... Read more Did you find an answer to your question? Yes No 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action in an inert gas atmosphere